Form 4: MACOM Technology Solutions SVP, Operations, Robert Dennehy, Sells Shares Under 10b5-1 Plan
SEC Form 4
Robert Dennehy, SVP of Operations at MACOM Technology Solutions Holdings, Inc., sold 2,370 shares of common stock at a price of $88.88 on March 15, 2024, under a pre-arranged 10b5-1 sales plan.
Summary
- Robert Dennehy, SVP of Operations at MACOM Technology Solutions Holdings, Inc., reported a transaction involving the company's common stock.
- On March 15, 2024, Dennehy sold 2,370 shares at a price of $88.88 per share.
- The sale was executed under a pre-arranged sales plan adopted on August 30, 2023, designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- Following the transaction, Dennehy directly owns 32,827 shares of MACOM Technology Solutions Holdings, Inc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged plan and doesn't inherently indicate a positive or negative outlook for the company.
Industry Context
Sales by company insiders are a common occurrence and are often scrutinized by investors. The use of a 10b5-1 plan allows insiders to sell shares over a predetermined period, mitigating concerns about trading on non-public information. It is important to note that insider sales do not necessarily indicate a negative outlook for the company.
Comparison to Industry Standards
- Comparing this transaction to similar insider sales at comparable semiconductor companies like Analog Devices (ADI) or Skyworks Solutions (SWKS) would require analyzing their respective Form 4 filings.
- Generally, the volume of shares sold is relatively small compared to the total outstanding shares of MACOM, suggesting it's unlikely to have a significant impact on the stock price.
- The use of a 10b5-1 plan is a standard practice among executives at publicly traded companies.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 08/30/2023 | Date the Reporting Person adopted the sales plan. |
| 03/15/2024 | Date of the stock sale transaction. |
| 03/19/2024 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.